Peripheral nerve disorder Peripheral nerve gap
Conditions
Interventions
Neurorapphy
E04-450-50
Nerve elongation
Sponsors
Yamazaki Masashi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who injured peripheral nerve defect of limbs 20 years old or more and less than 65 years old
Exclusion criteria
Exclusion criteria: The diabetic patient who is under medication The patient who have peripheral nerve disorder The patient who has a serious heart disorder The patient who has a doubt or diagnostic neoplastic lesion within 5 years before agreement The woman that during the pregnancy or the pregnancy is doubted The patient who received other study drugs within current 1 month. The patient who has not ability for agreement with own will. The patient who has not ability for agreement by the reading and writeing The patient who has been judged to be inappropriate as a subject by the doctor incharge
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety of the nerve lengthening method | — |
Secondary
| Measure | Time frame |
|---|---|
| Nerve regeneration( MMT, Semmes-Weinstein monofilament test,Tinel sign) Electromyography | — |
Contacts
Public ContactYuki Hara
University of Tsukuba Hospital
Outcome results
None listed